Latest stories on RXST
Rxsight’s Heavy Reliance on Alcon Poses Key Commercial and Royalty Risks
TipRanks34 · bearishgeneral
RXST Maintains Rating by Piper Sandler -- Price Target Lowered to $8.00
GuruFocus38 · neutralanalyst
RxSight (RXST) Q3 2026 Earnings Call Transcript
The Motley Fool34 · bearishearnings
RXST Maintains by Wells Fargo -- Price Target Lowered to $6.00
GuruFocus38 · neutralanalyst
RxSight price target lowered to $8 from $10 at Piper Sandler
The Fly34 · bearishanalyst
RxSight price target lowered to $6 from $9 at Wells Fargo
The Fly34 · bearishanalyst
RXST Maintained by Needham -- Price Target Lowered to $7.00
GuruFocus42 · neutralanalyst
RxSight (RXST) Reports Q3 Revenue Decline Amid Strategic Restructuring
GuruFocus38 · neutralearnings
Q3 2026 RxSight, Inc. Earnings Call Transcript
GuruFocus50 · neutralearnings
RxSight outlines 2028 earliest next-gen LAL timing as it plans to resume 2027 guidance
Seeking Alpha38 · neutralearnings
RxSight, Inc. (RXST) Q3 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
RxSight says nearly doubling sales force, completed organizational restructuring
The Fly63 · neutralproduct/pr
RxSight reports Q3 EPS (21c), consensus (29c)
The Fly34 · bearishearnings
RxSight Non-GAAP EPS of -$0.21 misses by $0.02, revenue of $24.6M misses by $2.59M
Seeking Alpha34 · bearishearnings
RxSight, Inc. (RXST) files 8-K
SEC 8-K50 · neutralgeneral
RxSight, Inc. Reports Third Quarter 2026 Results
StockTitan50 · neutralearnings
RxSight, Inc. Reports Third Quarter 2026 Results
GlobeNewswire50 · neutralearnings
Earnings To Watch: RxSight Inc (RXST) Q3 2026 -- GF Value Sees 515% Upside
GuruFocus64 · neutralearnings
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
StockTitan50 · neutralgeneral
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
GlobeNewswire48 · neutralgeneral
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
Business Insider50 · neutralgeneral
RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
Business Insider50 · neutralearnings
RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
GlobeNewswire50 · neutralgeneral
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
Business Insider58 · neutralproduct/pr